Академический Документы
Профессиональный Документы
Культура Документы
Definition
• Thought disorder that impairs judgement, behavior & ability to interpret reality which symptoms
present for at least 6 months
Causes
Clinical features
History MSE
• Hallucination – Most common: Auditory • Saccadic eye movements
• Delusions – Most common: Bizarre • Hypervigilance - anxiety
• Disorganized speech • Disheveled appearance
• Disorganized behavior • Flattened affect
• Catatonic behavior • Intact memory & orientation
• Negative symptoms • Ideas of reference
• Social & occupational dysfunction • Lack insight into their disease
DSM-5 Criteria
Criteria About
A Have at least 2 of following symptoms, must at least have one of these (1), (2), (3)
1. Delusions
2. Hallucination
3. Disorganized speech – Ex frequent derailment, incoherence
4. Disorganized behavior
5. Negative symptoms
B Decrease level of function
C At least for 6 months of continuous symptoms of criteria A
D Must rule out
• Schizoaffective disorder
• Depressive or bipolar disorder with mood symptoms
E Must rule out other causes
• Drug abuse or medication
Investigation
“Dear friends, the reason why we need to identify positive & negative symptoms predominance is to
determine type of treatment”
Subtypes of Schizophrenia
Differential diagnosis
• Substance induced – ecstasy, ketamine, phencyclidine, LSD (LSD – almost similar symptoms of
schizophrenia)
• Epilepsy
• Other psychotic disorder – Schizoaffective disorder, Brief reactive psychosis, delusional disorder
• Mood disorder
• Medical – HIV, corticosteroid, tumor
• Personality disorder
Treatment
Phase Condition & Treatment
Acute Condition Treatment
treatment Suicide risk, Aggressive • Hospitalization
Aggressive Rapid tranquilizer (Anti-psychotic)
• Oral: Lorazepam, Olanzapine or Risperidone
• IM: Haloperidol, Lorazepam
Acute Psychotic symptoms • Start with oral anti-psychotic (low dose)
• Monitor effectiveness & side effect for 2 months
Initial Condition Treatment
treatment Newly diagnose schizophrenia Oral antipsychotic – Olanzapine
• Monitor effectiveness for 1 month If no
adequate response or intolerable side effect
Change to another Anti-psychotic
No respond to medication, • ECT
Life threatening symptoms – catatonia,
severe depression
Stabilization Condition Treatment
phase Psychotherapy • Psychoeducation – on schizophrenia
• Cognitive behavioral therapy
• Problem solving therapy
Relapse of psychotic symptoms d/t • Long acting depot (IM Fluanxol, Clopixol)
non-compliance to medication
Post-psychotic depression • Anti-depressant
Maintenance Condition Treatment
phase Condition improve • Control condition with lowest effective dose of anti-psychotic
• Not up to 1/2 effective dose during acute phase
Drug side effect • Monitor & manage side effect
• If intolerable, change to another medication
• If use atypical drug, must regularly monitor metabolic side
effect (BMI, Blood glucose, Blood pressure, Lipid profile)
Acute relapse • Oral anti-psychotic drug
Prognosis
• 1/3 improve
• 1/3 remain the same
• 1/3 worsen